Umansky, J; Weber, M; Schild, H et al.
Combined immunotherapy against cancer: Limited efficacy of transcutaneous immunization and low-dose CyclophosphamideCancer and Oncology Res. Bd. 3. 2015 S. 1-9
Winzen, S.; Schoettler, S.; Baier, G. et al.
Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona compositionNANOSCALE. Bd. 7. H. 7. 2015 S. 2992-3001
Buhl, R; Burghuber, O; Geltner, C et al.
COPD - eine entzündliche ErkrankungIntrinsic Activity. Bd. 3. H. 1. 2015 S. e2
von Auer, Charis; von Krogh, Anne-Sophie; Hovinga, Johanna A. Kremer et al.
Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancyTHROMBOSIS RESEARCH. Bd. 135. 2015 S. S30-S33
Bateman, Eric D.; Buhl, Roland; O'Byrne, Paul M. et al.
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbationsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 135. H. 6. 2015 S. 1457-U102
Gerlach, Christina; Mai, Sandra; Schmidtmann, Irene et al.
Does Interdisciplinary and Multiprofessional Undergraduate Education Increase Students' Self-Confidence and Knowledge Toward Palliative Care? Evaluation of an Undergraduate Curriculum Design for Palliative Care at a German Academic HospitalJOURNAL OF PALLIATIVE MEDICINE. Bd. 18. H. 6. 2015 S. 513-519
Hess, G; Coiffier, B; Crump, M et al.
Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysisExp Hematol Oncol. Bd. 4. 2015 S. 11
Buhl, Roland; Gessner, Christian; Schuermann, Wolfgang et al.
Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority studyTHORAX. Bd. 70. H. 4. 2015 S. 311-+
Brightling, Christopher E.; Chanez, Pascal; Leigh, Richard et al.
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trialLANCET RESPIRATORY MEDICINE. Bd. 3. H. 9. 2015 S. 692-701
Hoffknecht, Petra; Tufman, Amanda; Wehler, Thomas et al.
Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)-Pretreated Non-Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal DiseaseJOURNAL OF THORACIC ONCOLOGY. Bd. 10. H. 1. 2015 S. 156-163